Knappertz Volker
EVP, Research and Development at AUPH; Director at GW PHARMACEUTICALS PLC
- Sold, on record
- $1.3M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Feb 27, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- AUPHAurinia Pharmaceuticals Inc.EVP, Research and Development
- GW PHARMACEUTICALS PLCDirector
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- GW PHARMACEUTICALS PLC93,804 shares
- AUPH30,076 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale GW PHARMACEUTICALS PLCPlan not statedAug 4, 2020 2020
Sold 6,000 shares at $11.11 ($67k)
Knappertz Volker, Chief Medical Officer
Sold 11.1% of holdings ($599k position)47,940 shares left1.4x usual sizeFiling
- 2 Form 4 sale GW PHARMACEUTICALS PLCPlan not statedNov 4, 2020 +92 days
Sold 6,000 shares at $9.17 ($55k)
Knappertz Volker, Chief Medical Officer
Sold 12.5% of holdings ($440k position)41,940 shares left1.2x usual sizeFiling
- 3 Form 4 sale GW PHARMACEUTICALS PLCPlan not statedNov 11, 2020 +7 days
Sold 6,000 shares at $10.00 ($60k)
Knappertz Volker, Chief Medical Officer
Sold 14.3% of holdings ($419k position)35,940 shares left1x usual sizeFiling
- 4 Form 4 sale GW PHARMACEUTICALS PLCUnusualNov 24, 2020 +13 days
Sold 12,000 shares at $10.50 ($126k)
Knappertz Volker, Chief Medical Officer
Sold 33.4% of holdings ($377k position)23,940 shares left2x usual sizeFiling
- 5 Form 4 sale GW PHARMACEUTICALS PLCUnusualJan 19, 2021 +56 days
Sold 6,000 shares at $11.67 ($70k)
Knappertz Volker, Chief Medical Officer
Sold 25.1% of holdings ($279k position)17,940 shares left1x usual sizeFiling
- 6 Form 4 sale GW PHARMACEUTICALS PLCPlan not statedMar 26, 2021 +66 days
Sold 3,060 shares at $18.10 ($55k)
Knappertz Volker, Director
Sold 3.2% of holdings ($1.7M position)92,412 shares left0.5x usual sizeFiling
- 7 Form 4 sale AUPHNo planFeb 20, 2024 +1061 days
Sold 25,146 shares at $5.48 ($138k)
Knappertz Volker, EVP, Research and Development
No 10b5-1 planSold 7.2% of holdings ($1.9M position)324,058 shares leftFirst sale on recordFiling
- 8 Form 4 sale AUPHNo planFeb 27, 2024 +7 days
Sold 4,930 shares at $6.10 ($30k)
Knappertz Volker, EVP, Research and Development
No 10b5-1 planSold 1.5% of holdings ($2M position)319,128 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Feb 29, 2024 | AUPH | EVP, Research and Development | Form 4 sale | 4,930 | $30k | 1.5% | No plan | SEC |
| Feb 20, 2024 | Feb 22, 2024 | AUPH | EVP, Research and Development | Form 4 sale | 25,146 | $138k | 7.2% | No plan | SEC |
| Mar 26, 2021 | Mar 30, 2021 | GW PHARMACEUTICALS PLC | Director | Form 4 sale | 3,060 | $55k | 3.2% | Plan not stated | SEC |
| Jan 19, 2021 | Jan 20, 2021 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 6,000 | $70k | 25.1% | Unusual | SEC |
| Nov 24, 2020 | Nov 25, 2020 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 12,000 | $126k | 33.4% | Unusual | SEC |
| Nov 11, 2020 | Nov 13, 2020 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 6,000 | $60k | 14.3% | Plan not stated | SEC |
| Nov 4, 2020 | Nov 5, 2020 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 6,000 | $55k | 12.5% | Plan not stated | SEC |
| Aug 4, 2020 | Aug 6, 2020 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 6,000 | $67k | 11.1% | Plan not stated | SEC |
| Jul 20, 2020 | Jul 22, 2020 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 6,000 | $69k | 10.0% | Plan not stated | SEC |
| Jun 17, 2020 | Jun 19, 2020 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 22,296 | $249k | 27.1% | Unusual | SEC |
| Mar 2, 2020 | Mar 4, 2020 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 3,420 | $28k | 4.1% | Plan not stated | SEC |
| Feb 26, 2020 | Feb 28, 2020 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 3,012 | $28k | 3.5% | Plan not stated | SEC |
| May 20, 2019 | May 21, 2019 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 12,144 | $178k | 12.4% | Plan not stated | SEC |
| Mar 1, 2019 | Mar 5, 2019 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 3,732 | $54k | 29.9% | Unusual | SEC |
| Feb 26, 2019 | Feb 28, 2019 | GW PHARMACEUTICALS PLC | Chief Medical Officer | Form 4 sale | 4,140 | $52k | 24.9% | Plan not stated | SEC |